PMID- 18219259 OWN - NLM STAT- MEDLINE DCOM- 20080502 LR - 20220331 IS - 0022-3069 (Print) IS - 0022-3069 (Linking) VI - 67 IP - 2 DP - 2008 Feb TI - Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy. PG - 93-104 LID - 10.1097/nen.0b013e3181630bb8 [doi] AB - To generate an experimental neuropathy model in which small-diameter sensory nerves are specifically affected and to test a potential treatment, adult mice were given a single injection (50 microg/kg, i.p.) of the capsaicin analog resiniferatoxin (RTX). On Day 7 after RTX treatment, there was a 53% reduction in unmyelinated nerve density in the medial plantar nerve (p = 0.0067) and a 66% reduction in epidermal nerve density of hind paw skin (p = 0.0004) compared with vehicle-treated controls. Substance P-immunoreactive dorsal root ganglion neurons were also markedly depleted (p = 0.0001). These effects were associated with the functional deficit of prolonged withdrawal latencies to heat stimuli (p = 0.0007) on a hot plate test. The potential therapeutic effects of 4-methylcatechol (4MC) on this neuropathy were then tested by daily injections of 4MC (10 microg/kg, i.p.) from Days 7 to 35 after neuropathy induction. On Day 35, 4MC-treated mice had an increase in unmyelinated (p = 0.014) and epidermal nerve (p = 0.0013) densities and a reduction in thermal withdrawal latency (p = 0.0091) compared with RTX-only controls. These results indicate that 4MC promoted regeneration of unmyelinated nerves in experimental RTX-induced neuropathy and enhanced function. FAU - Hsieh, Yu-Lin AU - Hsieh YL AD - Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, National Taiwan University Hospital, Taipei, Taiwan. FAU - Chiang, Hao AU - Chiang H FAU - Tseng, To-Jung AU - Tseng TJ FAU - Hsieh, Sung-Tsang AU - Hsieh ST LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Neuropathol Exp Neurol JT - Journal of neuropathology and experimental neurology JID - 2985192R RN - 0 (Catechols) RN - 0 (Diterpenes) RN - 0 (Neuroprotective Agents) RN - 12GLI7JGB3 (4-methylcatechol) RN - 33507-63-0 (Substance P) RN - A5O6P1UL4I (resiniferatoxin) RN - EC 3.4.19.12 (Ubiquitin Thiolesterase) RN - EC 3.4.19.12 (Uchl1 protein, mouse) RN - JHB2QIZ69Z (Calcitonin Gene-Related Peptide) RN - S07O44R1ZM (Capsaicin) SB - IM MH - Animals MH - Calcitonin Gene-Related Peptide/metabolism MH - Capsaicin MH - Catechols/*therapeutic use MH - Disease Models, Animal MH - *Diterpenes MH - Drug Interactions MH - Ganglia, Spinal/metabolism MH - Hyperalgesia/drug therapy MH - Male MH - Mice MH - Mice, Inbred ICR MH - Nerve Fibers, Unmyelinated/drug effects/pathology/ultrastructure MH - Nerve Regeneration/*drug effects/physiology MH - Neural Conduction/drug effects MH - Neuroprotective Agents/*therapeutic use MH - *Peripheral Nervous System Diseases/chemically induced/drug therapy/physiopathology MH - Reaction Time/drug effects MH - Skin/*innervation MH - Substance P/metabolism MH - Ubiquitin Thiolesterase/metabolism EDAT- 2008/01/26 09:00 MHDA- 2008/05/03 09:00 CRDT- 2008/01/26 09:00 PHST- 2008/01/26 09:00 [pubmed] PHST- 2008/05/03 09:00 [medline] PHST- 2008/01/26 09:00 [entrez] AID - 10.1097/nen.0b013e3181630bb8 [doi] PST - ppublish SO - J Neuropathol Exp Neurol. 2008 Feb;67(2):93-104. doi: 10.1097/nen.0b013e3181630bb8.